Ultimele actualizari :
08/05/2024
Diverse   Neostigmine methylsulfate  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie Pdf
   Formula chimica  

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adwigmine Egipt
Amostigmine Egipt
Beemine India
Bloxiverz
Epistigmine Egipt
Fadastigmina Argentina, Italia, Portugalia
Ipostigmine Iran
Miostin Romania
Neostig Germania
Neostigmin Germania, Suedia
Neostigmina Argentina, Chilli, Columbia, Ecuador, Peru, Portugalia, Spania, Venezuela
Neostigmine Arabia Saudita, Australia, Canada, Egipt, Grecia, Irlanda, Malaezia, Marea Britanie, Noua Zeelandă, Olanda, Turcia
Neostigmine methylsulfate Canada
Neostigten Peru
Normastigmin Austria
Planstigmin Turcia
Polstigminum Polonia
Prostigmin Austria, Belgia, Elvetia, Grecia, Malaezia, Olanda
Prostigmina Italia
Prostigmine Belgia, Chilli, Columbia, Egipt, Emiratele Arabe Unite, Franta, Luxemburg, Maroc, Mexic, Spania, Venezuela
Setisin Malaezia
Stigmosan Ungaria
Tigmin Peru
Visulmin Mexic
Stabilitatea in amestec   Injectabil   Stabilitatea in amestec : Neostigmine methylsulfate     
Continut Solvent Concentratie Molecula (substanta activa) Temperatura Conservare Durata stabilității Bibiografie
Sticla Fara 0,25 mg/ml
Injectabil   Neostigmine methylsulfate   
Injectabil   Palonosetron hydrochloride 25 µg/ml
25°C
4 Ora
Neprecizat 2286
Nivel de evidență A+
Polipropilen Clorura de sodiu 0,9% 0.167 mg/ml
Injectabil   Neostigmine methylsulfate   
Injectabil   Ondansetron hydrochloride 1,33 mg/ml
23°C
24 Ora
Ferit de lumina 815
Nivel de evidență C+
Polipropilen Clorura de sodiu 0,9% 0.167 mg/ml
Injectabil   Neostigmine methylsulfate   
Injectabil   Ondansetron hydrochloride 1,33 mg/ml
4°C
24 Ora
Ferit de lumina 815
Nivel de evidență C+

  Mentions Légales